Benitec Biopharma Inc. BNTC
9.47 USD +0.19 (+2.05%)
At closeNov 11, 2026, 4:00 PM EST
9.47 0.00 0.00%
After hours · Nov 11, 4:00 PM ET
9.20 Day range 9.59
7.89 52-week range 14.39
- YTD
- -29.70%
- 1 year
- -28.58%
Benzinga news
benzinga.com Benitec Biopharma Announces Its Interim Data From BB-301 Phase 1b/2a Trial Shows Continued Durable Enhancements In Participants Treated With Low Dose Of BB-301; 100% Response Rate Seen Across All Patients Treated Benitec Biopharma Inc. (NASDAQ: BNTC) ("Benitec" or "Company"), a clinical-stage, gene therapy-focused, biotechnology company developing novel genetic medicines based on its proprietary "Silence and
benzinga.com This Guardant Health Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday Analysts initiated coverage: VSE Sector Weight; Guardant, Quantum, Benitec and Diodes rated Buy/Overweight/Outperform with targets up to $200.
benzinga.com Raymond James Initiates Coverage On Benitec Biopharma with Outperform Rating, Announces Price Target of $14 Raymond James analyst Tiago Fauth initiates coverage on Benitec Biopharma (NASDAQ:BNTC) with a Outperform rating and announces Price Target of $14.